Upon activation, polymorphonuclear leucocytes (PMN) release bactericidal/permability-increasing protein, (BPI) from their azurophil granules. BPI selectively binds to the lipopolysaccharide (LPS) on gram-negative bacteria and induces their death. This study examined plasma BPI concentration levels in healthy newborns and in newborns with clinical sepsis, and the ability of PMN from preterm and term infants to release BPI. We also studied the release of myeloperoxidase (MPO), and the surface expression of adhesion molecule CD11b on PMN. In infants with clinical sepsis, plasma BPI concentration was higher, 27.8 g/L [8.6 -883; median (range)] (n ϭ 11), than in healthy term infants 8.9 g/L (3.9 -179) (n ϭ 17), and in adults 7.3 g/L (0.7 -18.4) (n ϭ 15); p ϭ 0.014, Kruskal-Wallis. In preterm infants (n ϭ 8), the ability of PMN to release BPI in vitro after stimulation with PMA was 8.8, in term infants it was 15.9 (n ϭ 29; p Ͼ 0.05 vs. preterm infants) and in adults 23.4 ng/10 6 PMN (n ϭ 15; p ϭ 0.024 and p Ͼ 0.05 vs. preterm and term infants, respectively Newborn infants, especially those born prematurely, are at risk for overwhelming bacterial infections. A number of immaturities in the host defense system have been reported in newborn infants. Among the immune mechanisms that apparently function suboptimally are the PMN (1). PMN contain multiple antibiotic proteins such as BPI, which is found in human PMN and eosinophils. BPI selectively binds to the LPS on the outer membrane of Gramnegative bacteria, causing immediate growth arrest followed by irreversible damage and then the death of the bacterium (2). BPI also blocks the endotoxic effects of LPS and promotes phagocytosis of BPI-coated bacteria (3, 4).BPI has been localized to azurophil granules, where its hydrophobic C-terminal end is believed to anchor it to the granule membrane. Studies of PMN conducted in vitro suggest that BPI is capable of acting against Gram-negative bacteria in the intracellular environment. Data on isolated cells stimulated to secrete granule contents in vitro and on plasma derived from animals and humans with sepsis in vivo have demonstrated that a portion of cellular BPI stores is released from stimulated PMN (5-9